Enliven Therapeutics, Inc. ELVN

Set alert

49.43 USD +4.64 (+10.36%)

At closeNov 9, 2026, 7:50 AM EST

50.19 +0.76 +1.54%

Pre-market · Nov 9, 7:50 AM ET

44.55 Day range 49.66

14.79 52-week range 62.32

Held by insiders 6.22%

Held by institutions 116.65%

Float held by institutions 124.39%

Institutions 307

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	13.68%	10,025,017	495.54M	Jun 29, 2026
Orbimed Advisors LLC.	9.25%	6,776,632	334.97M	Jun 29, 2026
Polar Capital Holdings PLC	8.78%	6,430,636	317.87M	Jun 29, 2026
Blackrock Inc.	5.95%	4,359,704	215.50M	Jun 29, 2026
Vestal Point Capital, LP	5.46%	4,000,000	197.72M	Jun 29, 2026
Commodore Capital Lp	4.47%	3,275,000	161.88M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.57%	1,883,372	93.10M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.06%	1,508,364	74.56M	Sep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio	1.75%	1,280,000	63.27M	Sep 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth Fund	1.71%	1,250,754	61.82M	Aug 30, 2026
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total	1.53%	1,123,263	55.52M	Sep 29, 2026
T. Rowe Price New Horizons Fund, Inc.	1.10%	807,329	39.91M	Jun 29, 2026

ELVN insiders
Insider	Relation	Latest transaction	Date	Shares held
COLLINS HELEN LOUISE	Officer	Sale	Oct 18, 2026	25,000
DERYNCK MIKA K	Director	Sale	Aug 3, 2026	0
GARLAND J SCOTT	Director	Sale	Sep 30, 2026	0
HEYMAN RICHARD A	Director	Sale	Feb 16, 2026	0
HOHL BENJAMIN	Chief Financial Officer	Sale	Oct 18, 2026	38,000
KINTZ SAMUEL	Chief Executive Officer	Sale	Nov 16, 2025	0

Held by funds